A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease

  1. Martin Wagner1,5,
  2. Florian R. Greten1,5,
  3. Christoph K. Weber1,
  4. Stefan Koschnick1,
  5. Torsten Mattfeldt2,
  6. Wolfgang Deppert3,
  7. Horst Kern4,
  8. Guido Adler1, and
  9. Roland M. Schmid1,6
  1. Departments of 1Internal Medicine I and 2Pathology, University of Ulm, 89081 Ulm, Germany; 3Heinrich Pette Institute for Experimental Virology and Immunology, University of Hamburg, 20246 Hamburg, Germany; 4Department of Cell Biology and Cell Pathology, University of Marburg, 35037 Marburg, Germany

Abstract

This study describes a tumor progression model for ductal pancreatic cancer in mice overexpressing TGF-α. Activation of Ras and Erk causes induction of cyclin D1-Cdk4 without increase of cyclin E or PCNA in ductal lesions. Thus, TGF-α is able to promote progression throughout G1, but not S phase. Crossbreeding with p53 null mice accelerates tumor development in TGF-α transgenic mice dramatically. In tumors developing in these mice, biallelic deletion ofInk4a/Arf or LOH of the Smad4 locus is found suggesting that loci in addition to p53 are involved in antitumor activities. We conclude that these genetic events are critical for pancreatic tumor formation in mice. This model recapitulates pathomorphological features and genetic alterations of the human disease.

Keywords

Footnotes

  • 5 These authors contributed equally to this work.

  • 6 Corresponding author.

  • E-MAIL roland.schmid{at}medizin.uni-ulm.de; FAX 49-731-500-24302.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.184701 .

    • Received July 7, 2000.
    • Accepted November 29, 2000.
| Table of Contents

Life Science Alliance